Brainstorm Cell Therapeutics (BCLI) Earnings
|
Expand Research on BCLI
| Next EPS Date | 11/16/26 | EPS Growth Rate | -10.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -5.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/26  |
Q326 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/17/26 | Q226 | -$0.35 | -$0.29 | -$0.06 | N/A | N/A | N/A |  | | Details | |
| 11/14/25 | Q325 | -$0.19 | $0.00 | -$0.19 | N/A | N/A | N/A | | | Details | |
| 8/14/25 |
Q225 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q225 | -$0.77 | $0.00 | -$0.77 | N/A | N/A | N/A | | | Details | |
| 5/15/25 | Q125 | -$0.45 | $0.00 | -$0.45 | N/A | N/A | N/A | | | Details | |
| 11/14/24 |
Q324 | -$1.80 | -$0.04 | -$1.76 | N/A | N/A | N/A | | | Details | |
| 8/14/24 | Q224 | -$0.04 | -$0.07 | +$0.03 | N/A | N/A | N/A | | | Details |
